Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Chemotherapy Intensification With BEACOPP in High-risk, Interim-PET Positive Advanced-stage Hodgkin Lymphoma:a GITIL Retrospective Multicenter Clinical Study

NCT00877747 is registered in ClinicalTrials.gov with Ospedale Santa Croce-Carle Cuneo as lead sponsor.

NCT NCT00877747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00877747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Chemotherapy Intensification With BEACOPP in High-risk, Interim-PET Positive Advanced-stage Hodgkin Lymphoma:a GITIL Retrospective Multicenter Clinical Study
Lead sponsor
Ospedale Santa Croce-Carle Cuneo
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2006
Completion date
October 31, 2015
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma